Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.5850 (0.41%) ($18.5850 - $18.5850) on Tue. Feb. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.24% (three month average) | RSI | 44 | Latest Price | $18.5850(0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.62% in a week (0% probabilities). VIXM(-35%) VXX(-27%) IGOV(-15%) UNG(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.62% (StdDev 3.24%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $19.16 | 5 Day Moving Average | $19.18(-3.1%) | 10 Day Moving Average | $19.47(-4.55%) | 20 Day Moving Average | $19.16(-3%) | To recent high | -29.4% | To recent low | 2% | Market Cap | $1.381b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |